Analysis of the oncogene BRAF mutation and the correlation of the expression of wild-type BRAF and CREB1 in endometriosis

Lv,Xiao; Wang,Danbo; Ma,Yue; Long,Zaiqiu

doi:10.3892/ijmm.2017.3342

Analysis of the oncogene BRAF mutation and the correlation of the expression of wild-type BRAF and CREB1 in endometriosis

Authors:
- Xiao Lv
- Danbo Wang
- Yue Ma
- Zaiqiu Long
View Affiliations

Affiliations: Department of Gynecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning 110042, P.R. China
Published online on: December 22, 2017 https://doi.org/10.3892/ijmm.2017.3342
Pages: 1349-1356
Copyright: © Lv et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

B-Raf proto-oncogene, serine/threonine kinase (BRAF) has previously been identified as a candidate target gene in endometriosis. Wild-type and mutated BRAF serve important roles in different diseases. The aim of the present study was to explore BRAF mutation, the mRNA and protein expression of wild-type BRAF (wtBRAF) in endometriosis, and the association between the expression levels of wtBRAF and the predicted transcription factor cAMP responsive element binding protein 1 (CREB1). In the present study, BRAF mutation was detected using Sanger sequencing among 30 ectopic and matched eutopic endometrium samples of patients with endometriosis as well as 25 normal endometrium samples, and no BRAF mutation was detected in exons 11 or 15. A region of ~2,000 bp upstream of the BRAF gene was then screened using NCBI and UCSC databases, and CREB1 was identified as a potential transcription factor of BRAF by analysis with the JASPAR and the TRANSFAC databases. Quantitative polymerase chain reaction was used to analysis the mRNA expression levels of wtBRAF and CREB1, and the corresponding protein expression levels were evaluated using immunohistochemistry and western blot analysis. The results revealed that the mRNA and protein expression levels of wtBRAF and CREB1 were significantly upregulated in the eutopic endometrial tissues of patients with endometriosis compared with normal endometrial tissues (P<0.05) and no significant difference in wtBRAF and CREB1 levels was detected between the ectopic and eutopic endometrium (P>0.05). In addition, correlation analysis revealed that the protein expression of CREB1 was positively correlated with the transcript level and protein expression of wtBRAF. It is reasonable to speculate that CREB1 may activate the transcription of wtBRAF through directly binding to its promoter, increasing BRAF expression and regulating the cell proliferation, migration and invasion of endometriosis.

View Figures

View References

1	Giudice LC and Kao LC: Endometriosis. Lancet. 364:1789–1799. 2004. View Article : Google Scholar : PubMed/NCBI
2	Liang Y, Li Y, Liu K, Chen P and Wang D: Expression and significance of WNT4 in ectopic and eutopic endometrium of human endometriosis. Reprod Sci. 23:379–385. 2016. View Article : Google Scholar
3	Gupta D, Hull ML, Fraser I, Miller L, Bossuyt PM, Johnson N and Nisenblat V: Endometrial biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 4:CD0121652016.PubMed/NCBI
4	Zhang Z, Chen P, Guo C, Meng X and Wang D: Effect of LIM kinase 1 overexpression on behaviour of endometriosis-derived stromal cells. Cell Tissue Res. 359:885–893. 2015. View Article : Google Scholar
5	Harada T, Kaponis A, Iwabe T, Taniguchi F, Makrydimas G, Sofikitis N, Paschopoulos M, Paraskevaidis E and Terakawa N: Apoptosis in human endometrium and endometriosis. Hum Reprod Update. 10:29–38. 2004. View Article : Google Scholar : PubMed/NCBI
6	Ulukus M, Cakmak H and Arici A: The role of endometrium in endometriosis. J Soc Gynecol Investig. 13:467–476. 2006. View Article : Google Scholar : PubMed/NCBI
7	Chen Q, Zhang C, Chen Y, Lou J and Wang D: Identification of endometriosis-related genes by representational difference analysis of cDNA. Aust N Z J Obstet Gynaecol. 52:140–145. 2012. View Article : Google Scholar : PubMed/NCBI
8	Xu YL, Wang DB, Liu QF, Chen YH and Yang Z: Silencing of cofilin-1 gene attenuates biological behaviours of stromal cells derived from eutopic endometria of women with endometriosis. Hum Reprod. 25:2480–2488. 2010. View Article : Google Scholar : PubMed/NCBI
9	Mitchell B, Dhingra JK and Mahalingam M: BRAF and epithelial-mesenchymal transition: Lessons from papillary thyroid carcinoma and primary cutaneous melanoma. Adv Anat Pathol. 23:244–271. 2016. View Article : Google Scholar : PubMed/NCBI
10	Rahman MA, Salajegheh A, Smith RA and Lam AK: B-Raf mutation: a key player in molecular biology of cancer. Exp Mol Pathol. 95:336–342. 2013. View Article : Google Scholar : PubMed/NCBI
11	Lopes JP and Fonseca E: BRAF gene mutation in the natural history of papillary thyroid carcinoma: diagnostic andprognostic implications. Acta Med Port. 24(Suppl 4): 855–868. 2011.
12	Ewing I, Pedder-Smith S, Franchi G, Ruscica M, Emery M, Vax V, Garcia E, Czirják S, Hanzély Z, Kola B, et al: A mutation and expression analysis of the oncogene BRAF in pituitary adenomas. Clin Endocrinol (Oxf). 66:348–352. 2007. View Article : Google Scholar
13	Yotova IY, Quan P, Leditznig N, Beer U, Wenzl R and Tschugguel W: Abnormal activation of Ras/Raf/MAPK and RhoA/ROCKII signalling pathways in eutopic endometrial stromal cells of patients with endometriosis. Hum Reprod. 26:885–897. 2011. View Article : Google Scholar : PubMed/NCBI
14	Chu DM, Wang DB, Li Y and Liu KR: Expression and significance of BRAF gene in ectopic endometrium of women with endometriosis. Zhongguo Yike Daxue Xuebao. 43:790–793. 2014.In Chinese.
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
16	Wang Y, Li Y, Yang Z, Liu K and Wang D: Genome-wide microarray analysis of long non-coding RNAs in eutopic secretory endometrium with endometriosis. Cell Physiol Biochem. 37:2231–2245. 2015. View Article : Google Scholar : PubMed/NCBI
17	Ikawa S, Fukui M, Ueyama Y, Tamaoki N, Yamamoto T and Toyoshima K: B-raf, a new member of the raf family, is activated by DNA rearrangement. Mol Cell Biol. 8:2651–2654. 1988. View Article : Google Scholar : PubMed/NCBI
18	Sclafani F, Gullo G, Sheahan K and Crown J: BRAF mutations in melanoma and colorectal cancer: a single oncogenic mutation with different tumour phenotypes and clinical implications. Crit Rev Oncol Hematol. 87:55–68. 2013. View Article : Google Scholar
19	Roskoski R Jr: RAF protein-serine/threonine kinases: Structure and regulation. Biochem Biophys Res Commun. 399:313–317. 2010. View Article : Google Scholar : PubMed/NCBI
20	Cohen Y, Goldenberg-Cohen N, Parrella P, Chowers I, Merbs SL, Pe'er J and Sidransky D: Lack of BRAF mutation in primary uveal melanoma. Invest Ophthalmol Vis Sci. 44:2876–2878. 2003. View Article : Google Scholar : PubMed/NCBI
21	Rimoldi D, Salvi S, Liénard D, Lejeune FJ, Speiser D, Zografos L and Cerottini JC: Lack of BRAF mutations in uveal melanoma. Cancer Res. 63:5712–5715. 2003.PubMed/NCBI
22	Zannoni GF, Improta G, Chiarello G, Pettinato A, Petrillo M, Scollo P, Scambia G and Fraggetta F: Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma. Virchows Arch. 465:193–198. 2014. View Article : Google Scholar : PubMed/NCBI
23	Newell P, Toffanin S, Villanueva A, Chiang DY, Minguez B, Cabellos L, Savic R, Hoshida Y, Lim KH, Melgar-Lesmes P, et al: Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol. 51:725–733. 2009. View Article : Google Scholar : PubMed/NCBI
24	Feng L, Li M, Zhang QP, Piao ZA, Wang ZH and Lv S: Utility of BRAF protein overexpression in predicting the metastasis potential of papillary thyroid carcinoma. Oncol Lett. 2:59–63. 2011. View Article : Google Scholar : PubMed/NCBI
25	Erhardt P, Schremser EJ and Cooper GM: B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol Cell Biol. 19:5308–5315. 1999. View Article : Google Scholar : PubMed/NCBI
26	Tanami H, Imoto I, Hirasawa A, Yuki Y, Sonoda I, Inoue J, Yasui K, Misawa-Furihata A, Kawakami Y and Inazawa J: Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines. Oncogene. 23:8796–8804. 2004. View Article : Google Scholar : PubMed/NCBI
27	Vestergaard AL, Thorup K, Knudsen UB, Munk T, Rosbach H, Poulsen JB, Guldberg P and Martensen PM: Oncogenic events associated with endometrial and ovarian cancers are rare in endometriosis. Mol Hum Reprod. 17:758–761. 2011. View Article : Google Scholar : PubMed/NCBI
28	Tan X, Wang S, Zhu L, Wu C, Yin B, Zhao J, Yuan J, Qiang B and Peng X: cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a. Proc Natl Acad Sci USA. 109:15805–15810. 2012. View Article : Google Scholar : PubMed/NCBI
29	Kong WQ, Bai R, Liu T, Cai CL, Liu M, Li X and Tang H: MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma. FEBS J. 279:1252–1260. 2012. View Article : Google Scholar : PubMed/NCBI
30	Yang Z, Tsuchiya H, Zhang Y, Hartnett ME and Wang L: MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein. J Biol Chem. 288:28893–28899. 2013. View Article : Google Scholar : PubMed/NCBI
31	Chhabra A, Fernando H, Watkins G, Mansel RE and Jiang WG: Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis. Oncol Rep. 18:953–958. 2007.PubMed/NCBI
32	Seo HS, Liu DD, Bekele BN, Kim MK, Pisters K, Lippman SM, Wistuba II and Koo JS: Cyclic AMP response element-binding protein overexpression: A feature associated with negative prognosis in never smokers with non-small cell lung cancer. Cancer Res. 68:6065–6073. 2008. View Article : Google Scholar : PubMed/NCBI